FDCA ALERT: Investigation into Suspected Counterfeit “Nicardia Retard 10” Tablets in Gujarat
The Gujarat Food and Drug Control Administration (FDCA) has initiated a massive state-wide investigation following the discovery of suspected counterfeit or duplicate Nicardia Retard 10 tablets. The drive, which started on 19 August 2026, has already covered over 30 medical stores and distributors to safeguard public health.
1. Primary Medicine Under Investigation
2. Seizure Details and Locations
3. Suspected Supply Chain Traceability
The FDCA has traced a potential distribution network originating from Uttar Pradesh to various agencies in Gujarat:
4. Other Medicines Under Scrutiny
In addition to the primary batch, samples of the following medicines have been collected for testing:
5. Vital Information for Pharmacists & Students
Important Note: Currently, these products are labeled as “Suspected Counterfeit.” Official status will only be confirmed after laboratory testing results are released.
- Verification: Always check Batch Number ACG25007 for Nicardia Retard 10.
- Documentation: Maintain 100% purchase invoice traceability and supplier records.
- Procurement: Purchase only through authorized pharmaceutical channels.
- Patient Safety: If a patient has this batch, advise them to consult their pharmacist or doctor. Do not abruptly stop cardiovascular medication.
6. Cities Covered in Investigation
Ahmedabad, Nadiad, Sanand, Surat, Junagadh, Bhavnagar, Gandhinagar, and Bhuj.
